Dehydroepiandrosterone (DHEA) is a hormone produced by your adrenal glands. It acts as a precursor, meaning your body converts it into other estrogens and androgens as needed.
A: Often, yes. A family history does not automatically disqualify you from HRT. We perform a detailed individual risk assessment. For many women, the benefits of bioidentical therapy (specifically transdermal estrogen + micronised progesterone) outweigh the risks, but this is a deeply personal decision we make together.
A: The North American Menopause Society (NAMS) suggests there is a “window of opportunity.” Starting HRT within 10 years of menopause (or under age 60) typically provides the maximum benefits for heart and brain health with the lowest risk profile.
A: Yes. You do not have to wait for your periods to stop. In fact, starting early can smooth the transition, regulating the chaotic hormonal fluctuations that cause mood swings and heavy bleeding.
A: No, not when dosed correctly. We prescribe micro-doses intended to restore female physiological levels, not male levels. We monitor your blood levels closely to prevent androgenic side effects.
A: Yes. Local vaginal estrogen is very low dose and stays in the pelvic tissue. It does not carry the same systemic risks as oral HRT and is considered safe for long-term use to prevent atrophy and discomfort.